Literature DB >> 20887336

New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma.

Yusuke Kawamura1, Kenji Ikeda, Miharu Hirakawa, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Hiromitsu Kumada.   

Abstract

AIM: The aim of this study was to elucidate whether the histopathological characteristics of hepatocellular carcinoma (HCC) can be predicted from baseline dynamic computed tomography (CT) images.
METHODS: This retrospective study included 86 consecutive patients with HCC who underwent surgical resection between January 2000 and September 2008. The arterial- and portal-phase dynamic CT images obtained preoperatively were classified into four enhancement patterns: Type-1 and Type-2 are homogeneous enhancement patterns without or with increased arterial blood flow, respectively; Type-3, heterogeneous enhancement pattern with septum-like structure; and Type-4, heterogeneous enhancement pattern with irregular ring-like structures. We also evaluated the predictive factors for poorly-differentiated HCC, specific macroscopic type of HCC (simple nodular type with extranodular growth [SNEG] and confluent multinodular [CMN]) by univariate and multivariate analyses.
RESULTS: The percentages of poorly-differentiated HCC according to the enhancement pattern were three of 51 nodules (6%) of Type-1 and -2, three of 24 (13%) of Type-3, and eight of 11 (73%) of Type-4. The percentages of SNEG/CMN according to the enhancement pattern were 12 of 51 nodules (24%) of Type-1 and -2, 13 of 24 (54%) of Type-3, and five of 11 (45%) of Type-4. Multivariate analysis identified Type-4 pattern as a significant and independent predictor of poorly-differentiated HCC (P < 0.001) while Type-3 pattern was a significant predictor of SNEG/CMN (P = 0.017).
CONCLUSION: Heterogeneity of dynamic CT images correlates with malignant characteristics of HCC and can be potentially used to predict the malignant potential of HCC before treatment.
© 2010 The Japan Society of Hepatology.

Entities:  

Year:  2010        PMID: 20887336     DOI: 10.1111/j.1872-034X.2010.00703.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  25 in total

1.  Proposal of objective morphological classification system for hepatocellular carcinoma using preoperative multiphase computed tomography.

Authors:  Hisashi Nakayama; Tadatoshi Takayama; Takao Okubo; Tokio Higaki; Yutaka Midorikawa; Masamichi Moriguchi; Akiyoshi Itoh
Journal:  J Gastroenterol       Date:  2013-11-16       Impact factor: 7.527

Review 2.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

Review 3.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

4.  A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RADS) categories and features.

Authors:  Alessandro Furlan; Omar Almusa; Robinson K Yu; Hersh Sagreiya; Amir A Borhani; Kyongtae T Bae; J Wallis Marsh
Journal:  Br J Radiol       Date:  2018-04-04       Impact factor: 3.039

5.  Evaluation of CT vascularization patterns for survival prognosis in patients with hepatocellular carcinoma treated by conventional TACE.

Authors:  Davut B Hasdemir; Lukas Aguirre Dávila; Nora Schweitzer; Bernhard C Meyer; Armin Koch; Arndt Vogel; Frank Wacker; Thomas Rodt
Journal:  Diagn Interv Radiol       Date:  2017 May-Jun       Impact factor: 2.630

Review 6.  Prognostic factors for hepatocellular carcinoma recurrence.

Authors:  Antonio Colecchia; Ramona Schiumerini; Alessandro Cucchetti; Matteo Cescon; Martina Taddia; Giovanni Marasco; Davide Festi
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

7.  Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.

Authors:  Hyun Jeong Park; Kyung Mi Jang; Tae Wook Kang; Kyoung Doo Song; Seong Hyun Kim; Young Kon Kim; Dong Ik Cha; Joungyoun Kim; Juna Goo
Journal:  Eur Radiol       Date:  2015-12-03       Impact factor: 5.315

8.  The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Yu Ohkura; Yusuke Kawamura; Masafumi Inoue; Masaji Hashimoto; Kenji Ikeda; Hiromitsu Kumada; Goro Watanabe
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

9.  The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma.

Authors:  Ryo Shimizu; Hideyuki Tamai; Yoshiyuki Mori; Naoki Shingaki; Shuya Maeshima; Junya Nuta; Yoshimasa Maeda; Kosaku Moribata; Yosuke Muraki; Hisanobu Deguchi; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Jun Kato; Masao Ichinose
Journal:  Hepatol Int       Date:  2015-11-03       Impact factor: 6.047

10.  Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features.

Authors:  Hyungjin Rhee; Chansik An; Hye-Young Kim; Jeong Eun Yoo; Young Nyun Park; Myeong-Jin Kim
Journal:  Liver Cancer       Date:  2018-05-15       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.